234 related articles for article (PubMed ID: 26954981)
1. Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.
Yamamura T; Okamoto Y; Okada G; Takaishi Y; Takamura M; Mantani A; Kurata A; Otagaki Y; Yamashita H; Yamawaki S
Transl Psychiatry; 2016 Mar; 6(3):e754. PubMed ID: 26954981
[TBL] [Abstract][Full Text] [Related]
2. Differences in fractional amplitude of low-frequency fluctuations (fALFF) and cognitive function between untreated major depressive disorder and schizophrenia with depressive mood patients.
Chen W; Liang J; Qiu X; Sun Y; Xie Y; Shangguan W; Zhang C; Wu W
BMC Psychiatry; 2024 Apr; 24(1):313. PubMed ID: 38658896
[TBL] [Abstract][Full Text] [Related]
3. Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment-resistant depression: A protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans.
Zhuo C; Tian H; Li G; Chen M; Jiang D; Lin X; Xu Y; Wang W
Brain Behav; 2019 Nov; 9(11):e01423. PubMed ID: 31617335
[TBL] [Abstract][Full Text] [Related]
4. Abnormal fractional amplitude of low-frequency fluctuations and regional homogeneity in major depressive disorder with non-suicidal self-injury.
Huang Y; Yan R; Zhang Y; Wang X; Sun H; Zhou H; Zou H; Xia Y; Yao Z; Shi J; Lu Q
Clin Neurophysiol; 2024 Jan; 157():120-129. PubMed ID: 38101296
[TBL] [Abstract][Full Text] [Related]
5. The potential predictors for treatment-resistance depression after selective serotonin reuptake inhibitors therapy in Han Chinese: A resting-state functional magnetic resonance imaging study.
Li Y; Yin Y; Yu Y; Hu X; Liu X; Wu S
Early Interv Psychiatry; 2024 Feb; ():. PubMed ID: 38320861
[TBL] [Abstract][Full Text] [Related]
6. Neurostructural Differences in Adolescents With Treatment-Resistant Depression and Treatment Effects of Transcranial Magnetic Stimulation.
Seewoo BJ; Rodger J; Demitrack MA; Heart KL; Port JD; Strawn JR; Croarkin PE
Int J Neuropsychopharmacol; 2022 Aug; 25(8):619-630. PubMed ID: 35089358
[TBL] [Abstract][Full Text] [Related]
7. A neuroimaging study of brain activity alterations in treatment-resistant depression after a dual target accelerated transcranial magnetic stimulation.
Liu J; Shu Y; Wu G; Hu L; Cui H
Front Psychiatry; 2023; 14():1321660. PubMed ID: 38288056
[TBL] [Abstract][Full Text] [Related]
8. Individualized diagnosis of major depressive disorder via multivariate pattern analysis of thalamic sMRI features.
Li H; Song S; Wang D; Tan Z; Lian Z; Wang Y; Zhou X; Pan C
BMC Psychiatry; 2021 Aug; 21(1):415. PubMed ID: 34416848
[TBL] [Abstract][Full Text] [Related]
9. Default mode network deactivation during emotion processing predicts early antidepressant response.
Spies M; Kraus C; Geissberger N; Auer B; Klöbl M; Tik M; Stürkat IL; Hahn A; Woletz M; Pfabigan DM; Kasper S; Lamm C; Windischberger C; Lanzenberger R
Transl Psychiatry; 2017 Jan; 7(1):e1008. PubMed ID: 28117844
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-1202 mediates Brodmann Area 44 functional connectivity changes in medication-free patients with major depressive disorder: An fMRI study.
Han S; Zheng Q; Zheng Z; Su J; Liu X; Shi C; Li B; Zhang X; Zhang M; Yu Q; Hou Z; Li T; Zhang B; Lin Y; Wen G; Deng Y; Liu K; Xu K
J Affect Disord; 2024 Jul; 356():470-476. PubMed ID: 38608766
[TBL] [Abstract][Full Text] [Related]
11. The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI.
Kraus C; Klöbl M; Tik M; Auer B; Vanicek T; Geissberger N; Pfabigan DM; Hahn A; Woletz M; Paul K; Komorowski A; Kasper S; Windischberger C; Lamm C; Lanzenberger R
Mol Psychiatry; 2019 May; 24(5):746-756. PubMed ID: 29422521
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression.
Zhdanava M; Karkare S; Pilon D; Joshi K; Rossi C; Morrison L; Sheehan J; Lefebvre P; Lopena O; Citrome L
Adv Ther; 2021 Sep; 38(9):4900-4916. PubMed ID: 34368919
[TBL] [Abstract][Full Text] [Related]
13. Modulation of inhibitory control networks relate to clinical response following ketamine therapy in major depression.
Sahib AK; Loureiro JR; Vasavada MM; Kubicki A; Wade B; Joshi SH; Woods RP; Congdon E; Espinoza R; Narr KL
Transl Psychiatry; 2020 Jul; 10(1):260. PubMed ID: 32732915
[TBL] [Abstract][Full Text] [Related]
14. Altered regional brain activity moderating the relationship between childhood trauma and depression severity.
Luo Z; Li W; Zhang F; Hu Z; You Z; Wang C; Lan X; Mai S; Chen X; Zeng Y; Chen Y; Liang Y; Chen Y; Zhou Y; Ning Y
J Affect Disord; 2024 Apr; 351():211-219. PubMed ID: 38244793
[TBL] [Abstract][Full Text] [Related]
15. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y
Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441
[TBL] [Abstract][Full Text] [Related]
16. Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans.
Liu F; Guo W; Yu D; Gao Q; Gao K; Xue Z; Du H; Zhang J; Tan C; Liu Z; Zhao J; Chen H
PLoS One; 2012; 7(7):e40968. PubMed ID: 22815880
[TBL] [Abstract][Full Text] [Related]
17. Abnormal amplitude of low-frequency fluctuations associated with sleep efficiency in major depressive disorder.
Li Y; Zhao W; Li X; Guan L; Zhang Y; Yu J; Zhu J; Zhu DM
J Psychiatr Res; 2024 May; 173():41-47. PubMed ID: 38479347
[TBL] [Abstract][Full Text] [Related]
18. Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study.
Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
Addiction; 2020 Apr; 115(4):768-777. PubMed ID: 31656053
[TBL] [Abstract][Full Text] [Related]
19. Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression.
Roy AV; Thai M; Klimes-Dougan B; Westlund Schreiner M; Mueller BA; Albott CS; Lim KO; Fiecas M; Tye SJ; Cullen KR
J Psychopharmacol; 2021 Feb; 35(2):168-177. PubMed ID: 32643995
[TBL] [Abstract][Full Text] [Related]
20. Electroconvulsive therapy treatment responsive multimodal brain networks.
Qi S; Abbott CC; Narr KL; Jiang R; Upston J; McClintock SM; Espinoza R; Jones T; Zhi D; Sun H; Yang X; Sui J; Calhoun VD
Hum Brain Mapp; 2020 May; 41(7):1775-1785. PubMed ID: 31904902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
